{"id":10030,"date":"2022-11-16T11:36:04","date_gmt":"2022-11-16T10:36:04","guid":{"rendered":"https:\/\/irlab.se\/?page_id=10030"},"modified":"2023-07-06T19:05:12","modified_gmt":"2023-07-06T17:05:12","slug":"valberedning-infor-arsstamma-2023","status":"publish","type":"page","link":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/","title":{"rendered":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\" id=\"foregaende-valberedning\">Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023<\/h1>\n\n\n\n<p>Enligt den instruktion f\u00f6r valberedning i IRLAB Therapeutics AB som antogs p\u00e5 \u00e5rsst\u00e4mman den 11 maj 2022 ska valberedningen, ut\u00f6ver styrelsens ordf\u00f6rande, best\u00e5 av representanter f\u00f6r de tre st\u00f6rsta aktie\u00e4garna, eller \u00e4gargrupperna, av Euroclear Sweden AB registrerade per den 31 augusti 2022.<\/p>\n\n\n\n<p>De tre st\u00f6rsta \u00e4garna eller \u00e4gargrupperna har nu utsett sina representanter varp\u00e5 valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2023 har f\u00f6ljande sammans\u00e4ttning:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clas Sonesson<\/strong>, forskningschef (CSO) p\u00e5 IRLAB och en av IRLAB:s grundare. Utsedd av en \u00e4gargrupp best\u00e5ende av bolagets grundare som representerar knappt 14 procent av aktier och r\u00f6ster;<\/li>\n\n\n\n<li><strong>Hans-Peter Ostler<\/strong>, bakgrund fr\u00e5n bank och investeringsr\u00e5dgivning, utsedd av en \u00e4gargrupp som representerar drygt 13 procent av aktier och r\u00f6ster; <\/li>\n\n\n\n<li><strong>Anders Vedin<\/strong>, bakgrund fr\u00e5n ledande positioner inom globala l\u00e4kemedelsf\u00f6retag, utsedd av en \u00e4gargrupp som representerar drygt 13 procent av aktier och r\u00f6ster; samt<\/li>\n\n\n\n<li><strong>Carola Lemne<\/strong>, styrelseordf\u00f6rande i IRLAB Therapeutics AB.<\/li>\n<\/ul>\n\n\n\n<p>Valberedningens ledam\u00f6ter \u00e4r utsedda av \u00e4gare som sammanlagt representerar cirka 40 procent av antalet r\u00f6stber\u00e4ttigade aktier i bolaget enligt \u00e4garf\u00f6rh\u00e5llanden per 30 maj 2023.<\/p>\n\n\n\n<p>Valberedningens f\u00f6rslag presenterades i kallelsen till \u00e5rsst\u00e4mman 2023 samt p\u00e5 bolagets hemsida:\u00a0<a href=\"https:\/\/www.irlab.se\/sv\/bolagsstyrning\/bolagsstamma\/\" target=\"_blank\" rel=\"noreferrer noopener\">www.irlab.se<\/a>.<\/p>\n\n\n\n<p>Aktie\u00e4gare som \u00f6nskade l\u00e4mna f\u00f6rslag till valberedningen skulle ha gjort detta skriftligen, senast den 31\u00a0januari 2023, per e-post\u00a0<a href=\"mailto:ir@irlab.se\" target=\"_blank\" rel=\"noreferrer noopener\">ir@irlab.se<\/a>\u00a0eller per brev till\u00a0bolagets postadress.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023 Enligt den instruktion f\u00f6r valberedning i IRLAB Therapeutics AB som antogs p\u00e5 \u00e5rsst\u00e4mman den 11 maj 2022 ska valberedningen, ut\u00f6ver styrelsens ordf\u00f6rande, best\u00e5 av representanter f\u00f6r de tre st\u00f6rsta aktie\u00e4garna, eller \u00e4gargrupperna, av Euroclear Sweden AB registrerade per den 31 augusti 2022. De tre st\u00f6rsta \u00e4garna eller \u00e4gargrupperna har nu utsett [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":578,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-10030","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023 Enligt den instruktion f\u00f6r valberedning i IRLAB Therapeutics AB som antogs p\u00e5 \u00e5rsst\u00e4mman den 11 maj 2022 ska valberedningen, ut\u00f6ver styrelsens ordf\u00f6rande, best\u00e5 av representanter f\u00f6r de tre st\u00f6rsta aktie\u00e4garna, eller \u00e4gargrupperna, av Euroclear Sweden AB registrerade per den 31 augusti 2022. De tre st\u00f6rsta \u00e4garna eller \u00e4gargrupperna har nu utsett [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-06T17:05:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/\",\"url\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/\",\"name\":\"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2022-11-16T10:36:04+00:00\",\"dateModified\":\"2023-07-06T17:05:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bolagsstyrning\",\"item\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Valberedning\",\"item\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/","og_locale":"sv_SE","og_type":"article","og_title":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023 - IRLAB","og_description":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023 Enligt den instruktion f\u00f6r valberedning i IRLAB Therapeutics AB som antogs p\u00e5 \u00e5rsst\u00e4mman den 11 maj 2022 ska valberedningen, ut\u00f6ver styrelsens ordf\u00f6rande, best\u00e5 av representanter f\u00f6r de tre st\u00f6rsta aktie\u00e4garna, eller \u00e4gargrupperna, av Euroclear Sweden AB registrerade per den 31 augusti 2022. De tre st\u00f6rsta \u00e4garna eller \u00e4gargrupperna har nu utsett [&hellip;]","og_url":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/","og_site_name":"IRLAB","article_modified_time":"2023-07-06T17:05:12+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/","url":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/","name":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2022-11-16T10:36:04+00:00","dateModified":"2023-07-06T17:05:12+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/valberedning-infor-arsstamma-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Bolagsstyrning","item":"https:\/\/irlab.se\/sv\/bolagsstyrning\/"},{"@type":"ListItem","position":3,"name":"Valberedning","item":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/"},{"@type":"ListItem","position":4,"name":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2023"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/10030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=10030"}],"version-history":[{"count":6,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/10030\/revisions"}],"predecessor-version":[{"id":10823,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/10030\/revisions\/10823"}],"up":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/578"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=10030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}